Great Bay Bio and Chime Biologics Deepen Strategic Collaboration to Accelerate Biologics Development with AI
GBB
AI Biomedical R&D Company
Today, Great Bay Bio announced a deep strategic partnership with Chime Biologics, a global leading CDMO company.This collaboration will deeply integrate GBB's intelligent drug development ecosystem with Chime Biologics' excellent CDMO service advantages to jointly accelerate global customers' biopharmaceutical development using cutting-edge technologies such as AI.
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
▲ Great Bay Bio and Chime Biologics Deepen Strategic Cooperation
According to the cooperation agreement, GBB will leverage its profound expertise in AI, big data mining, and automation, particularly its unique advantages in cell line construction, to provide comprehensive support for early drug discovery and subsequent bioprocess development.GBB and Chime Biologics will collaborate based on GBB's AlfaCell platform, the world's first commercially available targeted integration cell line construction platform, and Chime Biologics' excellent CDMO platform to help global customers obtain stable high-expression cell lines faster, with higher quality, and more intelligently, accelerating products into clinical trials and commercialization processes.
GBB and Chime Biologics' first strategic cooperation was disclosed in 2021, reaching a strategic cooperation in the Greater China region.
Dr. Liang Chen, Co-founder and CEO of Great Bay Bio, stated:"We are delighted to partner with Chime Biologics once again. With comprehensive biologics manufacturing capabilities and internationally recognized expertise, Chime Biologics is providing high-quality preclinical research, clinical trials, and commercial production services to customers worldwide. This aligns perfectly with GBB's innovative capabilities, accelerating the global commercialization of our intelligent technology platforms and making global biopharmaceutical development simpler and more efficient."
Chime Biologics President Jimmy Wei (魏建中) said:"The in-depth strategic cooperation between Chime Biologics and Great Bay Bio is highly aligned with the visions of both parties. The intelligent drug development ecosystem of Great Bay Bio, combined with the integrated CDMO services and technology platform of Chime Biologics, will further achieve complementary advantages. Together, we will explore and expand new models and pathways for biopharmaceutical development, providing more efficient and high-quality biopharmaceutical development services to global clients and delivering health benefits to patients."
Great Bay Bio is a high-tech biotechnology company driven by cutting-edge technologies such as artificial intelligence, big data mining, and automation to advance drug development, with its headquarters located in the Hong Kong Science Park. Guided by the corporate vision of "making global bioprocess development simpler and more efficient," Great Bay Bio is committed to addressing various pain points in drug development, such as long cycles, high costs, and low success rates, with the long-term goal of enhancing human health and value. For more information, please visit: www.greatbay-bio.com.cn.
Chime Biologics is a world-leading CDMO company that pioneered the introduction of KUBio™, the world’s first modular biopharmaceutical manufacturing facility, empowering the entire process from cell line development to commercial production of biologics. Our innovation center located in Shanghai focuses on efficient cell line development and advanced technology development, combined with our manufacturing facility in Wuhan, which has extensive experience in multi-national clinical trial applications and successful new drug launches. Chime Biologics is providing global biopharmaceutical clients with one-stop CMC solutions. At Chime Biologics, we share a common goal: to improve the accessibility of cutting-edge biopharmaceuticals for patients worldwide, fulfilling our commitment to human health. For more information, please visit: www.chimebiologics.com.